Get the Stockscreener App
2.07
2.48%
0.05
After Hours:
2.08
0.01
+0.48%
Protagenic Therapeutics Inc stock is traded at $2.07, with a volume of 56,058.
It is up +2.48% in the last 24 hours and down -33.65% over the past month.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.
See More
Previous Close:
$2.02
Open:
$1.99
24h Volume:
56,058
Relative Volume:
0.02
Market Cap:
$3.99M
Revenue:
-
Net Income/Loss:
$-5.00M
P/E Ratio:
-1.80
EPS:
-1.15
Net Cash Flow:
$-3.85M
1W Performance:
+1.97%
1M Performance:
-33.65%
6M Performance:
-66.29%
1Y Performance:
-75.68%
1-Day Range:
$1.9693
$2.15
1-Week Range:
$1.95
$2.248
52-Week Range:
$1.83
$14.28
Protagenic Therapeutics Inc Stock (PTIX) Company Profile
Name
Protagenic Therapeutics Inc
Sector
Industry
Phone
(212) 994-8200
Address
149 FIFTH AVENUE, NEW YORK
Compare PTIX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PTIX
Protagenic Therapeutics Inc
|
2.07 | 3.89M | 0 | -5.00M | -3.85M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Protagenic Therapeutics Inc Stock (PTIX) Latest News
Will Protagenic Therapeutics Inc. Equity Warrant stock benefit from upcoming earnings reportsTrade Entry Summary & Proven Capital Preservation Methods - newser.com
Is Protagenic Therapeutics Inc. Equity Warrant stock a buy before product launches2025 Macro Impact & Verified Momentum Watchlists - newser.com
Protagenic Therapeutics Inc. (PTIX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
What analysts say about Protagenic Therapeutics Inc Equity Warrant stockCapital Gains Strategies & Minimal Capital Growth Plans - earlytimes.in
How Protagenic Therapeutics Inc. Equity Warrant stock reacts to bond yieldsMarket Sentiment Review & Daily Momentum Trading Reports - newser.com
Can Protagenic Therapeutics Inc. (MBP0) stock hit consensus price targetsQuarterly Profit Report & Reliable Trade Execution Plans - newser.com
Building trade automation scripts for Protagenic Therapeutics Inc. Equity WarrantMarket Movement Recap & Risk Controlled Stock Alerts - newser.com
How Protagenic Therapeutics Inc. (MBP0) stock behaves in tightening cyclesPortfolio Profit Report & Daily Chart Pattern Signal Reports - newser.com
Why Protagenic Therapeutics Inc. (MBP0) stock could be next leader2025 Performance Recap & Free Expert Approved Momentum Trade Ideas - newser.com
Will Protagenic Therapeutics Inc. (MBP0) stock enhance shareholder valueMarket Risk Report & Capital Efficiency Focused Ideas - newser.com
Is Protagenic Therapeutics Inc. forming a reversal patternRate Cut & Long-Term Capital Growth Strategies - newser.com
Real time social sentiment graph for Protagenic Therapeutics Inc.2025 Biggest Moves & Verified Entry Point Detection - newser.com
Will Protagenic Therapeutics Inc. (MBP0) stock boost dividends further2025 Price Targets & Free Long-Term Investment Growth Plans - newser.com
Will Protagenic Therapeutics Inc. stock beat EPS estimates2025 Key Lessons & Fast Gain Stock Tips - newser.com
Will Protagenic Therapeutics Inc. Equity Warrant stock reach all time highs in 2025Weekly Trend Recap & Reliable Intraday Trade Plans - newser.com
Will Protagenic Therapeutics Inc. Equity Warrant rebound enough to break evenJuly 2025 Spike Watch & Long-Term Investment Growth Plans - newser.com
Relative strength of Protagenic Therapeutics Inc. Equity Warrant in sector analysisOptions Play & Fast Gain Stock Trading Tips - newser.com
Protagenic Therapeutics Delays Quarterly Report Filing - MSN
Why retail traders accumulate Protagenic Therapeutics Inc. (MBP0) stockPortfolio Risk Summary & Technical Pattern Based Buy Signals - newser.com
Evaluating Protagenic Therapeutics Inc. with trendline analysisEarnings Recap Report & Entry Point Confirmation Alerts - newser.com
Visual trend scoring systems applied to Protagenic Therapeutics Inc.2025 Market Overview & Reliable Volume Spike Alerts - newser.com
Is Protagenic Therapeutics Inc. Equity Warrant stock attractive after correctionJuly 2025 Levels & Reliable Momentum Entry Alerts - newser.com
How Protagenic Therapeutics Inc. (MBP0) stock performs in easing cyclesJuly 2025 Final Week & Weekly Setup with High ROI Potential - newser.com
What technical charts say about Protagenic Therapeutics Inc. stock2025 Price Action Summary & Safe Entry Trade Reports - newser.com
Protagenic Therapeutics Inc Stock (PTIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.38%
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):